| |
| |
|
| Insider
Information: |
Rhodes Jason P |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
138,000 |
|
|
Indirect Shares
|
23,308,240 |
|
|
| Direct
Value |
$202,860 |
|
|
|
Indirect Value
|
$420,842,579 |
|
|
| Total
Shares |
23,446,240 |
|
|
| Total
Value |
$421,045,439 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -2.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Epizyme, Inc. |
EPZM |
President, CFO and Tre... |
2014-09-22 |
138,000 |
2014-01-06 |
0 |
Premium* |
|
|
Replimune Group Inc |
REPL |
Director |
2018-07-24 |
0 |
2021-01-26 |
3,228,912 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
Director |
|
0 |
2021-09-29 |
8,279,484 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
|
|
0 |
2024-03-01 |
6,545,479 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
Director |
|
0 |
2021-02-05 |
5,254,365 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GBIO |
Generation Bio Co. |
Director |
– • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,590,726 |
|
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Director |
– • • |
2020-09-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,110,404 |
|
- |
|
| IRON |
Disc Medicine, Inc |
Director |
– • – |
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,254,365 |
|
- |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2018-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
4,453,386 |
4,453,386 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
10,040,032 |
12,630,758 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Director |
– • – |
2020-09-21 |
4 |
A |
$0.00 |
$0 |
I/I |
7,638,511 |
1,608,785 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-01-06 |
4 |
OE |
$0.51 |
$7,140 |
D/D |
14,000 |
14,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-02-10 |
4 |
OE |
$0.51 |
$187,200 |
D/D |
70,000 |
74,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-04-07 |
4 |
OE |
$0.51 |
$17,850 |
D/D |
35,000 |
59,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-05-05 |
4 |
OE |
$0.51 |
$133,530 |
D/D |
42,000 |
76,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-06-02 |
4 |
OE |
$0.51 |
$66,870 |
D/D |
42,000 |
88,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-07-07 |
4 |
OE |
$0.51 |
$39,960 |
D/D |
42,000 |
100,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-09-22 |
4 |
OE |
$0.51 |
$22,440 |
D/D |
44,000 |
138,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-08-04 |
4 |
OE |
$0.60 |
$48,720 |
D/D |
42,000 |
112,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-09-02 |
4 |
OE |
$0.60 |
$42,840 |
D/D |
42,000 |
124,000 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Director |
– • – |
2022-12-12 |
4 |
B |
$10.70 |
$10,000,017 |
I/I |
934,581 |
934,581 |
2.1 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2019-11-18 |
4 |
B |
$13.61 |
$14,971,000 |
I/I |
1,100,000 |
1,100,000 |
2.1 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-04-07 |
4 |
AS |
$20.05 |
$501,190 |
D/D |
(25,000) |
34,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-01-06 |
4 |
AS |
$20.19 |
$201,874 |
D/D |
(10,000) |
4,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-05-05 |
4 |
AS |
$21.53 |
$645,840 |
D/D |
(30,000) |
46,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-06-02 |
4 |
AS |
$22.14 |
$665,870 |
D/D |
(30,000) |
58,000 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-21 |
4 |
AS |
$22.44 |
$4,164,817 |
I/I |
(184,501) |
6,631,464 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-22 |
4 |
AS |
$22.66 |
$2,704,698 |
I/I |
(119,360) |
6,512,104 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-23 |
4 |
AS |
$22.70 |
$4,470,266 |
I/I |
(196,928) |
920,843 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-20 |
4 |
AS |
$22.71 |
$3,852,653 |
I/I |
(169,539) |
6,815,965 |
0 |
% |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
